Search results
New customised drug developed to fight aggressive breast cancer
Investing.com· 4 days agoNew customised drug developed to fight aggressive breast cancer
FDA withdraws Helsinn’s accelerated approval for cancer drug after company’s request
Endpoints News· 5 days agoThe FDA on Friday withdrew an accelerated approval for Helsinn’s bile duct cancer drug, two years...
Zantac not a cause of woman’s cancer, jury says in first trial over drug
Reuters via Yahoo News· 2 days agoA jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn...
Ovarian cancer drug developer's stock cut in half after it files for FDA approval - Boston Business...
The Business Journals· 1 day agoNeedham cancer drug developer Verastem Oncology saw its stock plunge over 60% Friday morning as of...
‘Lives will be cut short’ if drug not given to women with breast cancer
Press Association News via AOL· 1 day agoHealth officials and pharmaceutical companies have been urged to urgently work together to make a...
Scientists create tailored drug for aggressive breast cancer
Medical Xpress· 4 days agoScientists have used breast cancer cells' weakness against themselves by linking a tumor-selective...
Sean ‘Diddy’ Combs accused of raping, drugging former FIT student in the 90s: report
Page Six· 2 days agoApril Lampros alleged she was raped by the rapper on several occasions, recalling the moments he...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga via Yahoo Finance· 5 days agoDelaware federal jury has determined that AstraZeneca Plc (NASDAQ:AZN) must pay Pfizer Inc...
Blood test that detects colon cancer close to receiving FDA approval
News 12 New Jersey· 3 hours agoA blood test that detects colon cancer is one step closer to being approved by the Food and Drug Administration. The Guardant Shield blood test has been ...
AstraZeneca’s $80B sales plan leans on cancer drug expansion
BioPharma Dive via Yahoo Finance· 4 days agoAntibody-drug conjugates, which pair the tumor-targeting of antibodies with the cell-killing power...